The therapeutic role of nutraceuticals targeting the Nrf2/HO‐1 signaling pathway in liver cancer

KS Alharbi, WH Almalki, M Albratty… - Journal of Food …, 2022 - Wiley Online Library
Liver cancer (LC) is the most common cause of cancer death in the United States and the
fifth most common globally. The overexpression of nuclear factor E2 related factor 2 (Nrf2) …
被引用次数：20 相关文章

The therapeutic role of nutraceuticals targeting the Nrf2/HO-1 signaling pathway in liver cancer

KS Alharbi, WH Almalki, M Albratty… - Journal of food …, 2022 - pubmed.ncbi.nlm.nih.gov
Liver cancer (LC) is the most common cause of cancer death in the United States and the
fifth most common globally. The overexpression of nuclear factor E2 related factor 2 (Nrf2) …

The therapeutic role of nutraceuticals targeting the Nrf2/HO-1 signaling pathway in liver cancer.

KS Alharbi, WH Almalki, M Albratty… - Journal of Food …, 2022 - europepmc.org
Liver cancer (LC) is the most common cause of cancer death in the United States and the
fifth most common globally. The overexpression of nuclear factor E2 related factor 2 (Nrf2) …

[引用][C] The therapeutic role of nutraceuticals targeting the Nrf2/ HO ‐1 signaling pathway in liver cancer

KS Alharbi, WH Almalki, M Albratty… - Journal of Food …, 2022 - opus.lib.uts.edu.au
OPUS at UTS: The therapeutic role of nutraceuticals targeting the Nrf2/ <scp>HO</scp> ‐1
signaling pathway in liver cancer - Open Publications of UTS Scholars Skip navigation OPUS at …

The therapeutic role of nutraceuticals targeting the Nrf2/HO-1 signaling pathway in liver cancer.

KS Alharbi, WH Almalki, M Albratty, AM Meraya… - 2022 - cabidigitallibrary.org
Liver cancer (LC) is the most common cause of cancer death in the United States and the
fifth most common globally. The overexpression of nuclear factor E2 related factor 2 (Nrf2) …